Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

As the medical affairs and communications roles evolve, they have become essential to ensuring the successful launch of a product. It’s imperative for pharmaceutical, biotech, and medical device professionals to examine the pre-launch strategies, develop effective scientific, medical, and commercial communications, and build stakeholder partnerships. Medical Affairs holds responsibilities to support the commercialization process by bridging the product between the R&D Clinical Development Team to the Launch team for phase IV Clinical Development. Medical Affairs has obligations to support the commercialization process by bridging the product between the R&D Clinical Development Team to the Launch team for phase IV Clinical Development.

Due to the uncertainty surrounding Covid-19 pandemic, innovative engagement strategies must be quickly developed to adapt to this virtual world. The Launch Readiness for Medical Affairs and Communications Teams Summit will bring multiple stakeholders together, including medical affairs executives, payers, IDNs, and advocacy, to examine stakeholder engagement opportunities and overcome patient access challenges. Industry professionals will learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase the knowledge and communications with thought leaders.

WHAT’S NEW

As an added benefit, attendees will get an additional two days of content with a new perspective – New Product Planning. To learn more about what you will hear from your commercial colleagues on portfolio strategy and early decision making, click the button below.

February 2–3, 2021

Sponsoring Organizations